AVEO Oncology
AVEO
#7450
Rank
C$0.72 B
Marketcap
C$20.93
Share price
0.00%
Change (1 day)
171.05%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -C$37.21 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are C$94.31 Million. In 2021 the company made an earning of -C$74.45 Million a decrease over its 2020 earnings that were of -C$49.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$37.21 Million-50.03%
2021 -C$74.45 Million49.9%
2020 -C$49.67 Million-479.04%
2019 C$13.1 M-276.17%
2018 -C$7.44 Million-91.79%
2017 -C$90.62 Million142.38%
2016 -C$37.39 Million78.51%
2015 -C$20.95 Million-71.55%
2014 -C$73.61 Million-50.72%
2013 -C$0.15 Billion-4.88%
2012 -C$0.16 Billion-426.29%
2011 C$48.12 M-159.85%
2010 -C$80.42 Million35.33%
2009 -C$59.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
C$46.88 B-115,791.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.35 B-35,524.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$1.41 B-3,582.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.20 B-17,889.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.62 B-41,113.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-C$3.16 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA